Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24253138 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.
Conditions: The Primary Study Objective is to Assess the Efficacy and;   Safety of Extended 4-week Heparin Prophylaxis Compared to;   Prophylaxis Given for 8±2 Days After Planned Laparoscopic;   Surgery for Colorectal Cancer.;   The Clinical Benefit Will be Evaluated as the Difference in;   the Incidence of VTE or VTE-related Death Occurring Within 30 Days;   From Surgery in the Two Study Groups.
Intervention: Drug: Heparin, Low-Molecular-Weight

Indicates status has not been verified in more than two years